AI Article Synopsis

  • AJHP is posting accepted manuscripts online promptly to speed up publication, even before final formatting and author proofing are completed.
  • The article highlights the essential role of health-system pharmacists in managing drug formularies and resources, focusing on upcoming drug approvals that could impact clinical practices.
  • Anticipated drug approvals include new treatments for various cancers and rare diseases, with several innovative therapies and delivery methods under review by the FDA for the period of late 2024 to mid-2025.

Article Abstract

Purpose: Health-system pharmacists play a crucial role in monitoring the pharmaceutical pipeline to manage formularies, allocate resources, and optimize clinical programs for new therapies. This article aims to support pharmacists by sharing new and anticipated novel drug approvals.

Summary: Selected drug approvals anticipated in the 12-month period covering the third quarter of 2024 through the second quarter of 2025 are reviewed. The analysis emphasizes drugs expected to have significant clinical and financial impact in hospitals and clinics selected from 54 novel drugs awaiting US Food and Drug Administration approval. New cell therapies for treating cancers continue to enter the drug pipeline, while novel targeted therapies for biliary tract, gastric, pancreatic, and breast cancers, as well as 3 subcutaneous versions of already approved drugs given intravenously, are awaiting approval. Additionally, many novel drugs are being developed for treatment of rare and ultra-rare diseases such as hereditary angioedema, macular telangiectasia, congenital adrenal hyperplasia, and Barth syndrome. Two new subcutaneous drugs for hemophilia, a new oral medication for hereditary angioedema, a novel monoclonal antibody for atopic dermatitis, and the first oral penem antibiotic are also in the pipeline.

Conclusion: New drugs with various indications for cancers and rare diseases continue to strengthen the drug pipeline.

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajhp/zxae242DOI Listing

Publication Analysis

Top Keywords

anticipated novel
8
novel drug
8
drug approvals
8
novel drugs
8
drug pipeline
8
hereditary angioedema
8
drug
6
drugs
6
novel
5
approvals 2024
4

Similar Publications

Enhancing astaxanthin accumulation in immobilized Haematococcus pluvialis via alginate hydrogel membrane.

Int J Biol Macromol

December 2024

State Key Laboratory of Eco-chemical Engineering, College of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao 266042, China. Electronic address:

Immobilized cultivation is anticipated to be effective for enhancing both biomass and astaxanthin accumulation in Haematococcus pluvialis (H. pluvialis). A novel fabrication method of alginate hydrogel membrane (AHM) was introduced for immobilized cultivation of H.

View Article and Find Full Text PDF

Identifying malleable influences on eating behaviours will advance our ability to improve physical and mental health. Food-related emotional expectancies are the anticipated positive and negative emotions from eating different foods and are theorised to affect eating behaviour, and to be amenable to change. The Anticipated Effects of Food Scale (AEFS) assesses food-related emotional expectancies using 62 one-word items; however, a shorter questionnaire would be useful in large and clinical studies.

View Article and Find Full Text PDF

Heterogeneous Interface Engineering of 2D Black Phosphorus-Based Materials for Enhanced Photocatalytic Performance.

Small

December 2024

Hunan Key Laboratory for Micro-Nano Energy Materials and Devices, and School of Physics and Optoelectronic, Xiangtan University, Hunan, 411105, P. R. China.

Photocatalysis has garnered significant attention as a sustainable approach for energy conversion and environmental management. 2D black phosphorus (BP) has emerged as a highly promising semiconductor photocatalyst owing to its distinctive properties. However, inherent issues such as rapid recombination of photogenerated electrons and holes severely impede the photocatalytic efficacy of single BP.

View Article and Find Full Text PDF

Learning dynamic cognitive map with autonomous navigation.

Front Comput Neurosci

December 2024

Department of Engineering and Architecture, Ghent University/IMEC, Ghent, Belgium.

Inspired by animal navigation strategies, we introduce a novel computational model to navigate and map a space rooted in biologically inspired principles. Animals exhibit extraordinary navigation prowess, harnessing memory, imagination, and strategic decision-making to traverse complex and aliased environments adeptly. Our model aims to replicate these capabilities by incorporating a dynamically expanding cognitive map over predicted poses within an active inference framework, enhancing our agent's generative model plasticity to novelty and environmental changes.

View Article and Find Full Text PDF

Background: Using primary airway epithelial cells (AEC) is essential to mimic more closely different types and stages of lung disease in humans while reducing or even replacing animal experiments. Access to lung tissue remains limited because these samples are generally obtained from patients who undergo lung transplantation for end-stage lung disease or thoracic surgery for (mostly) lung cancer. We investigated whether forceps or cryo biopsies are a viable alternative source of AEC compared to the conventional technique.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!